Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
about
Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategyGenetic susceptibility to distinct bladder cancer subphenotypesForerunner genes contiguous to RB1 contribute to the development of in situ neoplasiaMolecular substratification of bladder cancer: moving towards individualized patient managementNew and contemporary markers of prognosis in nonmuscle invasive urothelial cancerCell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomenaSmall molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo.Genomic Landscape of Experimental Bladder Cancer in Rodents and Its Application to Human Bladder Cancer: Gene Amplification and Potential Overexpression of Cyp2a5/CYP2A6 Are Associated with the Invasive PhenotypePolymorphic variants of H-RAS protooncogene and their possible role in bladder cancer etiology.Molecular markers in transitional cell carcinoma of the bladder: New insights into mechanisms and prognosisFGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancerBioinformatic identification of FGF, p38-MAPK, and calcium signalling pathways associated with carcinoma in situ in the urinary bladder.Increased cell motility and invasion upon knockdown of lipolysis stimulated lipoprotein receptor (LSR) in SW780 bladder cancer cells.Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancerReduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts.Distinct microRNA alterations characterize high- and low-grade bladder cancerChromosomal aberrations in bladder cancer: fresh versus formalin fixed paraffin embedded tissue and targeted FISH versus wide microarray-based CGH analysis.A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.Analysis of tumor suppressor genes based on gene ontology and the KEGG pathway.MicroRNA-99a and 100 mediated upregulation of FOXA1 in bladder cancer.FGFR1-induced epithelial to mesenchymal transition through MAPK/PLCγ/COX-2-mediated mechanisms.Specific-mutational patterns of p53 gene in bladder transitional cell carcinoma among a group of Iraqi patients exposed to war environmental hazards.DNA copy number alterations and PPARG amplification in a patient with multifocal bladder urothelial carcinoma.Angiogenin promotes tumoral growth and angiogenesis by regulating matrix metallopeptidase-2 expression via the ERK1/2 pathway.The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancerCigarette smoking and subtypes of bladder cancerHyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesisOncogenic HRAS Activates Epithelial-to-Mesenchymal Transition and Confers Stemness to p53-Deficient Urothelial Cells to Drive Muscle Invasion of Basal Subtype CarcinomasThe long noncoding RNA HOTAIR has tissue and cell type-dependent effects on HOX gene expression and phenotype of urothelial cancer cells.CEBPD amplification and overexpression in urothelial carcinoma: a driver of tumor metastasis indicating adverse prognosis.Cruciferous vegetables, isothiocyanates, and prevention of bladder cancer.Impact of reduced levels of APE1 transcripts on the survival of patients with urothelial carcinoma of the bladder.Urothelial tumor initiation requires deregulation of multiple signaling pathways: implications in target-based therapies.Human papilloma virus is not detectable in samples of urothelial bladder cancer in a central European population: a prospective translational study.Epigenetic alterations in bladder cancer and their potential clinical implications.OASIS/CREB3L1 is epigenetically silenced in human bladder cancer facilitating tumor cell spreading and migration in vitroFGFR3b Extracellular Loop Mutation Lacks Tumorigenicity In Vivo but Collaborates with p53/pRB Deficiency to Induce High-grade Papillary Urothelial Carcinoma.The effect of gartanin, a naturally occurring xanthone in mangosteen juice, on the mTOR pathway, autophagy, apoptosis, and the growth of human urinary bladder cancer cell linesSurvival from bladder cancer in England and Wales up to 2001.Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target
P2860
Q24604540-0970D163-1585-4270-BB2F-BBCD2B9FE4EDQ24624419-816338A0-2F63-4718-A56C-DCCF1AAFC514Q24679141-305D12FD-13AA-4377-B6B7-0F2B7A29B9D8Q26744343-318A89D4-22D3-4228-BEA5-702421720B80Q26798006-98B29C8A-FC0B-44A5-92D9-3251824F2F43Q26860953-CB3F10EA-F82E-4F03-BA76-0FA4F26214C1Q27851612-7985E083-2EB9-4FFA-9147-64C87E59A273Q28395447-87E21933-2FDF-418A-889E-02B3FA9EA999Q30359594-21853604-67D0-4BBA-B178-A3E8945C1B0BQ30439612-52EBD9D5-0F3B-44EB-8FBD-C88DDFE51AE7Q33292711-23F96E1B-9C04-4AFB-BE80-B58B14987D98Q33317632-58132116-83DE-40C0-AEF7-3F175BCB6657Q33353831-5087448B-27D8-4A5F-908E-BB79C60CFEA5Q33554443-F831DC89-12DF-4478-A139-1DEC345FB5CBQ33726716-67F0061F-2310-49C6-8043-BD2EC1B334D3Q33854463-2A4CF880-B6BE-48C7-81CF-4716D26BA30EQ34016615-E4EE6D77-10D2-499E-9205-9CEA163F9D24Q34071175-5DA26635-84C9-471F-8138-9DA08CCC667CQ34160138-FEFBCDDE-0F12-4B86-8A15-1456D1FA2964Q34227727-0EED919C-B1DD-4EBD-89DC-E84DC8A039B1Q34305855-A321074E-F428-4D57-A5C7-448EBDC07B83Q34396704-826312E2-5495-4212-88DC-6892B76E4F6CQ34463194-4B7A5AE0-A7D9-46D6-92E8-8AC3271F3843Q35050128-61705C10-950E-4A66-9C8E-E701ABE9D011Q35214846-26230123-8EA6-4667-B950-052D2425315AQ35535796-C685FA16-E99F-4E2F-A63D-6BD9846DC333Q35589281-40DA56C1-BE98-4E48-B758-159BB9E75DF1Q35612218-12F26C4F-B0E6-49C0-BCF1-84D597F9853CQ35683471-97232A76-1199-4B42-8ED7-456D2E04545FQ35755517-110A5B95-B5A5-4F36-9E4B-FED6BFEB0F60Q35934829-1823BFE3-0E7D-42F7-ACEC-42CF554344B3Q36041736-EFADC234-8156-47C7-9BC3-12D724C772C6Q36061127-8EEF1635-AC67-4774-9479-DCE5A12F4DD9Q36076820-25D3E8CF-CF55-4EC1-AD71-D62FB767DA66Q36095721-7E0AB5D9-8D34-4F4C-A697-A21D86112B30Q36215429-B92D1BB1-3FD2-46A4-B7A8-432977DC448EQ36882005-09FC73E9-CA64-49A2-B09E-2FD2D0A1CB2AQ36899375-AA11DE3A-B94C-4558-8F13-FF2EBE18A701Q36917745-B7731D54-E955-4600-92E3-6DC44E5D74F6Q36958930-8FDD6BEF-A446-4544-9C6A-3E7B10B22D0C
P2860
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
@ast
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
@en
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
@en-gb
type
label
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
@ast
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
@en
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
@en-gb
prefLabel
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
@ast
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
@en
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
@en-gb
P2860
P356
P1433
P1476
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
@en
P2860
P304
P356
10.1093/CARCIN/BGI310
P407
P577
2005-12-13T00:00:00Z